Endovascular interventional treatment of anterior communicating aneurysm with unilateral moyamoya disease

doi:10.3877/cma.j.issn.2095-9141.2022.01.008

Abstract

Abstract:

Objective

To investigate the clinical effect of intravascular interventional treatment of anterior communicating aneurysm with unilateral moyamoya disease (MMD).

Methods

The clinical data of 8 cases of anterior communicating artery aneurysm with unilateral MMD who underwent intravascular interventional therapy in Vascular Neurosurgery Department of First Hospital of Jilin University were analyzed retrospectively from January 2017 to December 2019. The embolization method, postoperative effect and follow-up results were observed.

Results

Seven patients underwent successful embolization of aneurysm and were discharged after the operation; one aneurysm ruptured during the operation and died after the operation. The clinical and imaging follow-up ranged from 6 to 10 months, with an average of (7.9±1.4) months. Seven patients recovered well, none of the aneurysms recurred.

Conclusion

Endovascular interventional treatment of anterior communicating artery with unilateral MMD has a good clinical effect. It is a relatively safe and effective method. Its clinical effect still needs to be further confirmed by long-term follow-up and more cases.

Key words: Unilateral moyamoya disease, Anterior communicating aneurysm, Endovascular interventional therapy

Jianjun Xu, Honglei Wang, Meng Qiao, Yingli Feng, Ning Xu. Endovascular interventional treatment of anterior communicating aneurysm with unilateral moyamoya disease[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2022, 08(01): 39-43.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2022.01.008

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2022/V08/I01/39

Figures/Tables 3

References 16

[1]	Fujlmura M, Bang OY, Kim JS. Moyamoya disease[J]. Front Neurol Neurosci, 2016, 40: 204-220.
[2]	Zhang Q, Wang R, Liu Y, et al. Clinical features and long-term outcomes of unilateral moyamoya disease [J]. World Neurosurg, 2016, 96: 474-482.
[3]	Kim JH, Kwon TH, Kim JH, et al. Intracranial aneurysms in adult moyamoya disease[J]. World Neurosurg, 2018, 109: 175-182.
[4]	Furtado SV, Medress ZA, Teo M, et al. Pathogenesis of aneurysms on major vessels in moyamoya disease and management outcome[J]. J Clin Neurosci, 2019, 61: 219-224.
[5]	Kim S, Jang CK, Park EK, et al. Clinical features and outcomes of intracranial aneurysm associated with moyamoya disease[J]. J Clin Neurol, 2020, 16(4): 624-632.
[6]	Li Q, Qu L, Yuan Y, et al. Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: a single-center study of 212 cases[J]. Biomed Rep, 2018, 8(2): 191-197.
[7]	Zhang L, Xu K, Zhang Y, et al. Treatment strategies for aneurysms associated with moyamoya disease[J]. Int J Med Sci, 2015, 12(3): 234-242.
[8]	Yu JL, Wang HL, Xu K, et al. Endovascular treatment of intracranial aneurysms associated with moyamoya disease or moyamoya syndrome[J]. Interv Neuroradiol, 2010, 16(3): 240-248.
[9]	Yeon JY, Kim JS, Hong SC. Incidental major artery aneurysms in patients with non-hemorrhagic moyamoya disease[J]. Acta Neurochir (Wien), 2011, 153(6): 1263-1270.
[10]	Ni W, Jiang H, Xu B, et al. Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience[J]. J Neurosurg, 2018, 128(6): 1813-1822.
[11]	Choi HH, Cho YD, Yoo DH, et al. Comparative analysis of coil embolization in posterior and anterior communicating artery aneurysms [J]. J Neurointerv Surg, 2019, 11(8): 790-795.
[12]	Chen Y, Dai D, Fang Y, et al. Endovascular treatment of ruptured large or wide-neck basilar tip aneurysms associated with moyamoya disease using the stent-assisted coil technique[J]. J Stroke Cerebrovasc Dis, 2015, 24(10): 2229-2235.
[13]	Shang S, Zhou D, Ya J, et al. Progress in moyamoya disease[J]. Neurosurg Rev, 2020, 43(2): 371-382.
[14]	Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of willis)[J]. Neurol Med Chir (Tokyo), 2012, 52(5): 245-266.
[15]	Natarajan SK, Karmon Y, Tawk RG, et al. Endovascular treatment of patients with intracranial stenosis with moyamoya-type collaterals[J]. J Neurointerv Surg, 2011, 3(4): 369-374.
[16]	Khan N, Dodd R, Marks MP, et al. Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in moyamoya angiopathy[J]. Cerebrovasc Dis, 2011, 31(2): 147-153.

患者编号	性别	年龄（岁）	起病方式	烟雾病侧别	动脉瘤侧别	铃木分期	Hunt-Hess分级
1	男	64	SAH	左	左	Ⅲ	Ⅱ
2	女	69	脑缺血	左	左	Ⅳ	0
3	男	57	SAH	右	右	Ⅲ	Ⅱ
4	女	52	SAH	右	左	Ⅳ	Ⅲ
5	女	54	SAH	右	左	Ⅲ	Ⅱ
6	男	47	SAH	左	左	Ⅳ	Ⅱ
7	男	64	SAH	左	右	Ⅴ	Ⅰ
8	男	45	脑缺血	右	右	Ⅱ	0

患者编号	性别	年龄（岁）	起病方式	烟雾病侧别	动脉瘤侧别	铃木分期	Hunt-Hess分级
1	男	64	SAH	左	左	Ⅲ	Ⅱ
2	女	69	脑缺血	左	左	Ⅳ	0
3	男	57	SAH	右	右	Ⅲ	Ⅱ
4	女	52	SAH	右	左	Ⅳ	Ⅲ
5	女	54	SAH	右	左	Ⅲ	Ⅱ
6	男	47	SAH	左	左	Ⅳ	Ⅱ
7	男	64	SAH	左	右	Ⅴ	Ⅰ
8	男	45	脑缺血	右	右	Ⅱ	0

患者编号	栓塞方式	并发症	术后即刻效果（Raymond分级）	出院时评分（mRs评分）	随访时间（月）	影像学随访（Raymond分级）	临床随访（mRs评分）
1	单纯弹簧圈栓塞	一过性失语	Ⅰ	3	10	Ⅰ	1
2	支架辅助栓塞	无	Ⅰ	1	6	Ⅰ	0
3	单纯弹簧圈栓塞	无	Ⅱ	2	6	Ⅱ	1
4	单纯弹簧圈栓塞	术中破裂	Ⅱ	死亡	-	-	-
5	单纯弹簧圈栓塞	无	Ⅰ	3	7	Ⅰ	1
6	单纯弹簧圈栓塞	无	Ⅱ	2	8	Ⅰ	0
7	支架辅助栓塞	无	Ⅱ	2	8	Ⅰ	1
8	单纯弹簧圈栓塞	无	Ⅰ	1	9	Ⅰ	0

患者编号	栓塞方式	并发症	术后即刻效果（Raymond分级）	出院时评分（mRs评分）	随访时间（月）	影像学随访（Raymond分级）	临床随访（mRs评分）
1	单纯弹簧圈栓塞	一过性失语	Ⅰ	3	10	Ⅰ	1
2	支架辅助栓塞	无	Ⅰ	1	6	Ⅰ	0
3	单纯弹簧圈栓塞	无	Ⅱ	2	6	Ⅱ	1
4	单纯弹簧圈栓塞	术中破裂	Ⅱ	死亡	-	-	-
5	单纯弹簧圈栓塞	无	Ⅰ	3	7	Ⅰ	1
6	单纯弹簧圈栓塞	无	Ⅱ	2	8	Ⅰ	0
7	支架辅助栓塞	无	Ⅱ	2	8	Ⅰ	1
8	单纯弹簧圈栓塞	无	Ⅰ	1	9	Ⅰ	0

Please choose a citation manager

Content to export